CD8A and malignant mesothelioma: Moreover, we demonstrate that tumor-specific cytotoxic CD8+ T cells, but neither CD4+ T cells nor antibodies, confer the protection, suggesting that CD8+ T cells may play a central role in antigen spreading-mediated immunotherapeutic efficacy against malignant mesothelioma in mice.